Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel FTase inhibitors in early development at Janssen

July 15, 2002

Dyax acquires exclusive rights to a newly discovered prostate cancer target

July 15, 2002

Phase III patient enrollment complete for histrelin implant

July 15, 2002

Plans discussed for Exherin phase I clinical trials

July 12, 2002

MediciNova acquires worldwide rights to novel cancer treatment

July 12, 2002

Selective CCK2 antagonist undergoes clinical evaluation at JB for pancreatic cancer

July 12, 2002

Combinations containing TT-232 and cytostatics examined in murine models

July 12, 2002

CPI-0004Na more effective than doxorubicin against lung metastases

July 12, 2002

New steroid 17-20 lyase inhibitors identified by Takeda R&D team

July 11, 2002

Potential use of a combination of two recombinant adenoviral vectors in cancer gene therapy

July 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...